(Reuters) -The U.S. Food and Drug Administration has approved the generic version of the abortion drug, mifepristone, the regulator said in a letter dated September 30.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Alan Barona)

See Full Page